Metabolic Disturbances Independent of Body Mass in Patients with Schizophrenia Taking Atypical Antipsychotics

Associations between smoking, components of metabolic syndrome and lipoprotein particle size

(2013) Sandra N Slagter et al.   BMC Medicine

Antipsychotic-Induced Metabolic and Cardiovascular Side Effects in Schizophrenia: A Novel Mechanistic Hypothesis

(2013) Giulio Scigliano et al.   CNS DRUGS

Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease

(2013) Karen L. Teff et al.   DIABETES

Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia

(2013) Hu Yan et al.   PSYCHOPHARMACOLOGY

Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro

(2012) Alberto Canfrán-Duque et al.   JOURNAL OF LIPID RESEARCH

Hypertriglyceridemia secondary to obesity and diabetes

(2011) Savitha Subramanian et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

(2011) Marc De Hert et al.   Nature Reviews Endocrinology

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices

(2011) A. J. Mitchell et al.   PSYCHOLOGICAL MEDICINE

Cross-sectional prevalence of metabolic syndrome in Korean patients with schizophrenia

(2011) Shi Hyun Kang et al.   SCHIZOPHRENIA RESEARCH

Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons

(2010) Christine Rummel-Kluge et al.   SCHIZOPHRENIA BULLETIN

In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment

(2009) Gerald M. Reaven et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Olanzapine-induced Elevation of Serum Triglyceride Levels in a Normal Weight Patient with Schizophrenia

(2008) Takahiko Nagamine   INTERNAL MEDICINE

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH